Research Analysts’ updated eps estimates for Wednesday, August 9th:

Agilent Technologies (NYSE:A) had its buy rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $66.00 target price on the stock.

Alcoa Corp. (NYSE:AA) had its hold rating reiterated by analysts at Deutsche Bank AG. They currently have a $44.00 price target on the stock.

Apple (NASDAQ:AAPL) had its buy rating reiterated by analysts at Drexel Hamilton. The firm currently has a $208.00 price target on the stock.

Arbor Realty Trust (NYSE:ABR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Arbor Realty Trust is a specialized real estate finance company investing in real estate-related bridge and mezzanine loans, preferred equity, mortgage-related securities and other real estate-related assets. “

First Majestic Silver Corp. (NYSE:AG) (TSE:FR) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “First Majestic Silver Corp. is engaged in the production, development, exploration, and acquisition of silver mines in Mexico. First Majestic Silver Corp. is headquartered in Vancouver, Canada. “

Allergan PLC. (NYSE:AGN) had its outperform rating reiterated by analysts at UBS AG. They currently have a $275.00 target price on the stock.

Amazon.com (NASDAQ:AMZN) had its buy rating reaffirmed by analysts at Tigress Financial.

ANI Pharmaceuticals (NASDAQ:ANIP) had its buy rating reaffirmed by analysts at Canaccord Genuity. The analysts wrote, “We remain pessimistic about the company’s ability to execute a successful clinical trial required for FDA approval. The planned 2018 $10M cost-cutting initiative suggests to us that Eagle isn’t too confident either (and is generally in line with our expectations). Eagle’s other pipeline programs like fulvestrant and drug-induced hyperthermia are questionable and may require a few more years of development under a best case scenario, in our view. There was strangely no mention of the Alimta RTD PDUFA in October. Eagle also reiterated prior 2017 expense guidance of $50-$53M in SG&A (excluding stock based comp) and $26- $30M R&D (excluding stock-based comp). We note the company was previously reporting GAAP earnings so the change is slightly new. We also note that Eagle has expanded its borrowing capacity by $100M (suggesting to us that it may want to bring in new assets) but simultaneously announced an additional $100M buyback program.””

Accuray (NASDAQ:ARAY) had its buy rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $7.00 target price on the stock.

Amerigo Resources (NASDAQ:ARREF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Amerigo Resources Ltd., through its subsidiary, is engaged in producing and selling copper and molybdenum concentrates primarily in Chile. Amerigo Resources Ltd. is headquartered in Vancouver, Canada. “

Athene Holding (NYSE:ATH) was upgraded by analysts at Wells Fargo & Company to a buy rating.

Best Buy Co. (NYSE:BBY) had its hold rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $60.00 target price on the stock.

Ball Corporation (NYSE:BLL) had its hold rating reissued by analysts at Vertical Group. Vertical Group currently has a $43.00 target price on the stock, up from their previous target price of $41.50.

Bluerock Residential Growth REIT (NYSE:BRG) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bluerock Residential Growth REIT, Inc. operates as a real estate investment trust. It acquires apartment properties in demographically attractive growth markets throughout the United States. Bluerock Residential Growth REIT, Inc. is based in New York. “

CommerceHub (NASDAQ:CHUBA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CommerceHub, Inc. provides distributed commerce network which connecting supply, demand and delivery for retailers and brands. CommerceHub, Inc. is headquartered in Albany, United States. “

Crocs (NASDAQ:CROX) had its hold rating reissued by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $9.00 price target on the stock.

Control4 Corporation (NASDAQ:CTRL) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $25.00 price target on the stock. According to Zacks, “Control4 Corporation is engaged in providing automation and control solutions for the connected home. The Company offers home operating system that interacts with various music, video, lighting, temperature, security, and communications. It also provides 4Sight subscription services, which allow consumers to control and monitor their homes remotely from their smartphone, tablet, or laptop. Control4 Corporation is headquartered in Salt Lake City, Utah. “

DCT Industrial Trust (NYSE:DCT) had its buy rating reiterated by analysts at Stifel Nicolaus. They currently have a $60.00 target price on the stock, up from their previous target price of $58.00.

Deere & (NYSE:DE) had its hold rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $125.00 target price on the stock.

Dollar Tree (NASDAQ:DLTR) had its buy rating reiterated by analysts at Loop Capital. The firm currently has a $86.00 price target on the stock.

Dynavax Technologies Corporation (NASDAQ:DVAX) had its outperform rating reissued by analysts at William Blair. They currently have a $30.00 price target on the stock.

Dextera Surgical (NASDAQ:DXTR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Dextera Surgical Inc. designs and manufactures proprietary stapling devices for surgical procedures. The company’s product consists of MicroCutter 5/80 use for transection and resection in urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the intestine and the transection of the appendix. Dextera Surgical Inc., formerly known as Cardica Inc., is headquartered in Redwood City, California. “

EMCORE (NASDAQ:EMKR) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “EMCORE Corporation offers a broad portfolio of compound semiconductor- based products for the broadband, fiber optic, satellite and terrestrial solar power markets. EMCORE’s Fiber Optic segment offers optical components, subsystems and systems for high-speed data and telecommunications networks, cable television and fiber-to-the-premises. EMCORE’s Photovoltaic segment provides products for both satellite and terrestrial applications. For satellite applications, EMCORE offers high efficiency Gallium Arsenide solar cells, Covered Interconnect Cells and panels. For terrestrial applications, EMCORE is adapting its high-efficiency GaAs solar cells for use in solar power concentrator systems. “

Epizyme (NASDAQ:EPZM) had its outperform rating reaffirmed by analysts at Leerink Swann. The firm currently has a $28.00 target price on the stock, down from their previous target price of $31.00.

Eros International PLC (NYSE:EROS) had its outperform rating reiterated by analysts at Wells Fargo & Company.

Fossil Group (NASDAQ:FOSL) had its hold rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $16.00 target price on the stock.

Gevo (NASDAQ:GEVO) had its buy rating reissued by analysts at Rodman & Renshaw. Rodman & Renshaw currently has a $12.00 price target on the stock.

GoPro (NASDAQ:GPRO) had its market perform rating reissued by analysts at Oppenheimer Holdings, Inc..

G1 THERAPEUTICS (NASDAQ:GTHX) had its buy rating reaffirmed by analysts at Cowen and Company. The analysts wrote, “G1 Therapeutics ended Q2 with $133MM in cash following completion of an IPO in.””

Humana (NYSE:HUM) had its neutral rating reissued by analysts at UBS AG. The firm currently has a $250.00 price target on the stock, up from their previous price target of $237.00.

Horizon Pharma PLC (NASDAQ:HZNP) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $17.00 price target on the stock, up from their previous price target of $13.00.

Icahn Enterprises L.P. (NASDAQ:IEP) had its buy rating reiterated by analysts at Jefferies Group LLC. They currently have a $61.00 target price on the stock.

II-VI (NASDAQ:IIVI) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $45.00 target price on the stock, up from their previous target price of $40.00.

Kite Pharma (NASDAQ:KITE) had its buy rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $135.00 target price on the stock.

LKQ Corporation (NASDAQ:LKQ) had its buy rating reissued by analysts at Jefferies Group LLC. The firm currently has a $37.00 price target on the stock.

LogMein (NASDAQ:LOGM) had its overweight rating reaffirmed by analysts at Piper Jaffray Companies. They currently have a $170.00 price target on the stock.

Meredith Corporation (NYSE:MDP) had its hold rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $60.00 price target on the stock.

Mimecast (NASDAQ:MIME) had its buy rating reissued by analysts at Jefferies Group LLC. The firm currently has a $35.00 target price on the stock.

Marathon Oil Corporation (NYSE:MRO) had its buy rating reissued by analysts at KLR Group. The firm currently has a $23.00 price target on the stock, up from their previous price target of $21.00.

Manitowoc Company, Inc. (The) (NYSE:MTW) had its buy rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $9.50 price target on the stock.

Nabors Industries (NYSE:NBR) had its neutral rating reissued by analysts at Citigroup Inc.. Citigroup Inc. currently has a $9.00 target price on the stock, down from their previous target price of $10.00.

Universal Display Corporation (NASDAQ:OLED) had its market perform rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

ON Semiconductor Corporation (NASDAQ:ON) had its hold rating reissued by analysts at Jefferies Group LLC. They currently have a $16.00 target price on the stock.

ON Semiconductor Corporation (NASDAQ:ON) had its outperform rating reiterated by analysts at Mizuho. Mizuho currently has a $19.00 target price on the stock, up from their previous target price of $18.00.

OSI Systems (NASDAQ:OSIS) had its buy rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $85.00 target price on the stock.

Premier (NASDAQ:PINC) had its buy rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $40.00 target price on the stock.

Radcom (NASDAQ:RDCM) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $27.00 target price on the stock.

RMR Group (NYSE:RMR) had its buy rating reiterated by analysts at Canaccord Genuity. Canaccord Genuity currently has a $72.00 price target on the stock. The analysts wrote, “We note that we are primarily focused on EBITDA and AUM growth, as transaction costs and one time items can sway EPS materially. With solid activity at all of the managed REITs including the $1.4B FPO acquisition and completed $289M of acquisitions, we believe RMR is finding ways to build AUM accretively. While GOV, HPT, and SIR were all down in the quarter, we note that GOV was not expected to generate an incentive management fee for 2017 anyway, while HPT is still well above the incentive fee cap on our estimates. SNH stock price increased modestly in the quarter, and should build upon our previously forecasted incentive fee payment.””

Standard Motor Products (NYSE:SMP) had its buy rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $60.00 target price on the stock.

Snap (NYSE:SNAP) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $31.00 target price on the stock.

Snap (NYSE:SNAP) had its buy rating reiterated by analysts at Drexel Hamilton. They currently have a $30.00 target price on the stock.

Staples (NASDAQ:SPLS) had its hold rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $9.00 target price on the stock.

Syros Pharmaceuticals (NASDAQ:SYRS) had its buy rating reaffirmed by analysts at Cowen and Company.

Terreno Realty Corporation (NYSE:TRNO) had its buy rating reissued by analysts at Stifel Nicolaus. The firm currently has a $37.00 target price on the stock, up from their previous target price of $34.50.

Trivago N.V. ADS (NASDAQ:TRVG) had its market perform rating reissued by analysts at Cowen and Company. They currently have a $18.00 target price on the stock, down from their previous target price of $20.00.

Trivago N.V. ADS (NASDAQ:TRVG) had its neutral rating reissued by analysts at Susquehanna Bancshares Inc. The firm currently has a $21.00 price target on the stock, down from their previous price target of $23.00.

Tesla (NASDAQ:TSLA) had its market perform rating reissued by analysts at Oppenheimer Holdings, Inc..

Tyson Foods (NYSE:TSN) had its buy rating reissued by analysts at Mizuho. Mizuho currently has a $76.00 price target on the stock, up from their previous price target of $71.00.

Viacom (NASDAQ:VIA) had its buy rating reissued by analysts at UBS AG. UBS AG currently has a $45.00 target price on the stock, down from their previous target price of $50.00.

Valeant Pharmaceuticals International (NYSE:VRX) (TSE:VRX) had its underperform rating reissued by analysts at Mizuho. Mizuho currently has a $8.00 target price on the stock.

Boingo Wireless (NASDAQ:WIFI) had its outperform rating reiterated by analysts at Oppenheimer Holdings, Inc.. Oppenheimer Holdings, Inc. currently has a $24.00 price target on the stock, up from their previous price target of $18.00.

Yelp (NYSE:YELP) had its sell rating reaffirmed by analysts at UBS AG. They currently have a $30.00 price target on the stock, up from their previous price target of $28.00.

Zynerba Pharmaceuticals (NASDAQ:ZYNE) had its buy rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $12.00 target price on the stock, down from their previous target price of $32.00.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.